Literature DB >> 22305054

Acute exacerbation of usual interstitial pneumonia after resection of lung cancer.

Hiroaki Sugiura1, Atsuya Takeda, Toshiko Hoshi, Yoshinori Kawabata, Koichi Sayama, Masahiro Jinzaki, Sachio Kuribayashi.   

Abstract

BACKGROUND: Acute exacerbation of usual interstitial pneumonia is one of the most life-threatening complications after resection of lung cancer. It is important to detect patients at high risk for acute exacerbation. The purpose of this study was to investigate the incidence of postoperative acute exacerbation and the importance of the finding of honeycombing in predicting the risk of it.
METHODS: From 992 consecutive pulmonary resections for lung cancer, the background lung was retrospectively assessed histologically. Preoperative chest computed tomographic images of those patients with histologically proven usual interstitial pneumonia were retrospectively reassessed and classified into three groups: typical honeycombing, possible honeycombing, and no honeycombing. Records of patients who experienced postoperative acute exacerbation were extracted from the clinical database, and the correlation between computed tomographic findings and incidence of acute exacerbation was analyzed.
RESULTS: Of the 992 lung cancer patients, 12 (1.2%) experienced postoperative acute exacerbation. Usual interstitial pneumonia was histologically confirmed in 249 patients, and 4.8% of them experienced postoperative acute exacerbation. No patient without usual interstitial pneumonia experienced it. Preoperative computed tomographic images were available in 205 of the 249 patients. Postoperative acute exacerbation developed in 13.6% of patients (6 of 44 patients) in the typical honeycombing group, 6.4% of patients (5 of 78 patients) in the possible honeycombing group, and 0% of patients (0 of 83 patients) in the no-honeycombing group. Compared with the no-honeycombing group, the incidence of acute exacerbation in the typical and possible honeycombing groups was significantly higher (p=0.001, p=0.025, respectively).
CONCLUSIONS: Physicians should consider the finding of possible honeycombing, as well as typical honeycombing, a potential risk factor for acute exacerbation after pulmonary resection for lung cancer.
Copyright © 2012 The Society of Thoracic Surgeons. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22305054     DOI: 10.1016/j.athoracsur.2011.12.010

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  14 in total

Review 1.  Lung cancer and interstitial lung disease: a literature review.

Authors:  Jean-Marc Naccache; Quentin Gibiot; Isabelle Monnet; Martine Antoine; Marie Wislez; Christos Chouaid; Jacques Cadranel
Journal:  J Thorac Dis       Date:  2018-06       Impact factor: 2.895

2.  Acute Exacerbation of Idiopathic Pulmonary Fibrosis: A Proposal.

Authors:  Kerri Johannson; Harold R Collard
Journal:  Curr Respir Care Rep       Date:  2013-12

3.  Distribution of interstitial pneumonia: a new radiological predictor of 90-day mortality after resection of lung cancer.

Authors:  Mariko Fukui; Kenji Suzuki; Shiaki Oh; Takeshi Matsunaga; Yoshikazu Miyasaka; Izumi Kawagoe; Kazuya Takamochi
Journal:  Surg Today       Date:  2015-03-05       Impact factor: 2.549

4.  Experience with perioperative pirfenidone for lung cancer surgery in patients with idiopathic pulmonary fibrosis.

Authors:  Takekazu Iwata; Shigetoshi Yoshida; Kaoru Nagato; Takahiro Nakajima; Hidemi Suzuki; Tetsuzo Tagawa; Teruaki Mizobuchi; Satoshi Ota; Yukio Nakatani; Ichiro Yoshino
Journal:  Surg Today       Date:  2014-11-22       Impact factor: 2.549

5.  Accuracy and complications of percutaneous transthoracic needle lung biopsy for the diagnosis of malignancy in patients with idiopathic pulmonary fibrosis.

Authors:  Yoon Joo Shin; Gabin Yun; Sung Hyun Yoon; Hwayoung Song; Junghoon Kim; Jihang Kim; Jong Sun Park; Kyoung Won Lee; Kyung Hee Lee
Journal:  Eur Radiol       Date:  2021-05-18       Impact factor: 5.315

6.  Impact of Preexisting Interstitial Lung Disease on Acute, Extensive Radiation Pneumonitis: Retrospective Analysis of Patients with Lung Cancer.

Authors:  Yuichi Ozawa; Takefumi Abe; Minako Omae; Takashi Matsui; Masato Kato; Hirotsugu Hasegawa; Yasunori Enomoto; Takeaki Ishihara; Naoki Inui; Kazunari Yamada; Koshi Yokomura; Takafumi Suda
Journal:  PLoS One       Date:  2015-10-13       Impact factor: 3.240

7.  Early Detection of the Acute Exacerbation of Interstitial Pneumonia after the Surgical Resection of Lung Cancer by Planned Chest Computed Tomography.

Authors:  Kunihiro Oyama; Masato Kanzaki; Mitsuko Kondo; Hideyuki Maeda; Kei Sakamoto; Tamami Isaka; Jun Tamaoki; Takamasa Onuki
Journal:  Korean J Thorac Cardiovasc Surg       Date:  2017-06-05

8.  Clarithromycin mitigates radiation pneumonitis in patients with lung cancer treated with stereotactic body radiotherapy.

Authors:  Atsuya Takeda; Yuichiro Tsurugai; Naoko Sanuki; Tatsuji Enomoto; Masaharu Shinkai; Tomikazu Mizuno; Yousuke Aoki; Yohei Oku; Takeshi Akiba; Yu Hara; Etsuo Kunieda
Journal:  J Thorac Dis       Date:  2018-01       Impact factor: 2.895

Review 9.  Managing comorbidities in idiopathic pulmonary fibrosis.

Authors:  Blair G Fulton; Christopher J Ryerson
Journal:  Int J Gen Med       Date:  2015-09-22

10.  A phase II trial evaluating the efficacy and safety of perioperative pirfenidone for prevention of acute exacerbation of idiopathic pulmonary fibrosis in lung cancer patients undergoing pulmonary resection: West Japan Oncology Group 6711 L (PEOPLE Study).

Authors:  Takekazu Iwata; Ichiro Yoshino; Shigetoshi Yoshida; Norihiko Ikeda; Masahiro Tsuboi; Yuji Asato; Nobuyuki Katakami; Kazuhiro Sakamoto; Yoshinori Yamashita; Jiro Okami; Tetsuya Mitsudomi; Motohiro Yamashita; Hiroshi Yokouchi; Kenichi Okubo; Morihito Okada; Mitsuhiro Takenoyama; Masayuki Chida; Keisuke Tomii; Motoki Matsuura; Arata Azuma; Tae Iwasawa; Kazuyoshi Kuwano; Shuji Sakai; Kenzo Hiroshima; Junya Fukuoka; Kenichi Yoshimura; Hirohito Tada; Kazuhiko Nakagawa; Yoichi Nakanishi
Journal:  Respir Res       Date:  2016-07-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.